Axon Enterprise, Inc. (NASDAQ:AXON) Shares Acquired by Avior Wealth Management LLC

Avior Wealth Management LLC increased its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 3.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,995 shares of the biotechnology company’s stock after acquiring an additional 86 shares during the period. Avior Wealth Management LLC’s holdings in Axon Enterprise were worth $1,197,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of AXON. Acadian Asset Management LLC purchased a new position in shares of Axon Enterprise in the first quarter valued at approximately $2,137,000. O Shaughnessy Asset Management LLC lifted its holdings in Axon Enterprise by 55.4% during the 1st quarter. O Shaughnessy Asset Management LLC now owns 1,986 shares of the biotechnology company’s stock worth $621,000 after buying an additional 708 shares in the last quarter. UniSuper Management Pty Ltd grew its stake in shares of Axon Enterprise by 388.4% in the first quarter. UniSuper Management Pty Ltd now owns 3,819 shares of the biotechnology company’s stock worth $1,195,000 after acquiring an additional 3,037 shares in the last quarter. CANADA LIFE ASSURANCE Co raised its stake in shares of Axon Enterprise by 74.2% in the first quarter. CANADA LIFE ASSURANCE Co now owns 89,861 shares of the biotechnology company’s stock valued at $28,114,000 after acquiring an additional 38,269 shares in the last quarter. Finally, Shell Asset Management Co. boosted its holdings in Axon Enterprise by 223.0% in the first quarter. Shell Asset Management Co. now owns 3,585 shares of the biotechnology company’s stock valued at $1,122,000 after purchasing an additional 2,475 shares during the period. 79.08% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

AXON has been the topic of several recent research reports. Barclays increased their price target on Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a research report on Wednesday, August 7th. JMP Securities lifted their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research note on Thursday, October 31st. Craig Hallum increased their price objective on shares of Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a research report on Wednesday, August 7th. The Goldman Sachs Group raised their price objective on shares of Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Finally, Northland Securities increased their target price on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $427.83.

Axon Enterprise Price Performance

AXON stock opened at $609.82 on Thursday. The business has a 50 day simple moving average of $453.48 and a 200-day simple moving average of $363.68. The company has a market capitalization of $46.50 billion, a P/E ratio of 157.58, a PEG ratio of 15.05 and a beta of 0.94. Axon Enterprise, Inc. has a twelve month low of $224.28 and a twelve month high of $624.84. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Insider Buying and Selling

In other Axon Enterprise news, CFO Brittany Bagley sold 4,338 shares of the stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $378.95, for a total transaction of $1,643,885.10. Following the completion of the sale, the chief financial officer now directly owns 98,825 shares of the company’s stock, valued at approximately $37,449,733.75. This trade represents a 4.20 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, President Joshua Isner sold 25,811 shares of the business’s stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $359.84, for a total value of $9,287,830.24. Following the completion of the transaction, the president now directly owns 228,166 shares in the company, valued at approximately $82,103,253.44. The trade was a 10.16 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 410,556 shares of company stock worth $161,192,754 in the last 90 days. Company insiders own 5.70% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.